BlackRock Inc. Takes $1.08 Billion Position in The Cooper Companies, Inc. $COO

BlackRock Inc. bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 15,029,453 shares of the medical device company’s stock, valued at approximately $1,077,762,000. BlackRock Inc. owned about 0.08% of Cooper Companies as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after purchasing an additional 7,363 shares during the period. First Trust Advisors LP boosted its holdings in shares of Cooper Companies by 115.8% during the second quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after acquiring an additional 73,165 shares during the period. Cresset Asset Management LLC acquired a new position in shares of Cooper Companies in the second quarter valued at approximately $291,000. Cerity Partners LLC grew its position in shares of Cooper Companies by 4.4% in the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock valued at $1,272,000 after purchasing an additional 757 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its stake in shares of Cooper Companies by 2.8% during the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after purchasing an additional 973 shares during the period. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Up 0.1%

Shares of NASDAQ:COO opened at $76.22 on Friday. The firm has a market cap of $14.87 billion, a P/E ratio of 64.59, a P/E/G ratio of 1.99 and a beta of 0.83. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The business has a fifty day simple moving average of $71.93 and a 200 day simple moving average of $71.16. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Piper Sandler set a $86.00 price target on Cooper Companies and gave the company an “overweight” rating in a research note on Monday, June 1st. Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. JPMorgan Chase & Co. dropped their target price on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a report on Friday, June 5th. Stifel Nicolaus reduced their target price on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Finally, BNP Paribas Exane decreased their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research note on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $81.64.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.